Business Combinations Business Combinations

12 Months Ended

Jun. 30, 2015

Business Combinations [Abstract]

Business Combination Disclosure

BUSINESS COMBINATIONS

During the twelve months endedJune 30, 2015, the Company completed acquisitions which were immaterial, individually and in the aggregate, to the overall consolidated financial position and results of operations of the Company. Notably, in October 2014, the Company acquired the remaining shares of Redwood Bioscience Inc. and its SMARTag Antibody-Drug Conjugate (ADC) technology platform.  The acquired business is based in the U.S. and is included in the Medication Delivery Solutions segment.  Additionally, in November 2014, the Company acquired 100% of the shares of MTI Pharma Solutions, Inc. (Micron Technologies), a company specializing in particle size reduction (micronization), milling and analytical contract services. The acquired business is based in the U.S. and the U.K. and is included in the Development and Clinical Services segment.

The Company’s consolidated balance sheet as of June 30, 2015 includes the fair value allocation for these acquisitions which was completed in the fiscal year. Aggregate purchase consideration for both acquisitions totaled $110.8 million. As a result of the preliminary fair value allocation, the Company recognized intangible assets of $56 million, comprised of $34 million of Customer Relationships and $22 million of Core Technology. The remainder of fair value was allocated to tangible assets acquired and goodwill.